FGFR1OP Antikörper (AA 1-70)
Kurzübersicht für FGFR1OP Antikörper (AA 1-70) (ABIN7267172)
Target
Alle FGFR1OP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-70
-
Verwendungszweck
- FGFR1OP Rabbit pAb
-
Sequenz
- MAATAAAVVA EEDTELRDLL VQTLENSGVL NRIKAELRAA VFLALEEQEK VENKTPLVNE SLKKFLNTKD
-
Kreuzreaktivität
- Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-70 of human FGFR1OP (NP_919410.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- FGFR1OP (FGFR1 Oncogene Partner (FGFR1OP))
-
Andere Bezeichnung
- FGFR1OP
-
Hintergrund
- This gene encodes a largely hydrophilic centrosomal protein that is required for anchoring microtubules to subcellular structures. A t(6;8)(q27;p11) chromosomal translocation, fusing this gene and the fibroblast growth factor receptor 1 (FGFR1) gene, has been found in cases of myeloproliferative disorder. The resulting chimeric protein contains the N-terminal leucine-rich region of this encoded protein fused to the catalytic domain of FGFR1. Alterations in this gene may also be associated with Crohn's disease, Graves' disease, and vitiligo. Alternatively spliced transcript variants that encode different proteins have been identified. [provided by RefSeq, Jul 2013],FGFR1OP;FOP,Cancer,Cell Biology & Developmental Biology,Cell Cycle,Centrosome,Growth factor,FGFR1OP
-
Molekulargewicht
- 16kDa/40kDa/43kDa
-
Gen-ID
- 11116
-
UniProt
- O95684
-
Pathways
- M Phase, Maintenance of Protein Location, SARS-CoV-2 Protein Interaktom
Target
-